ロード中...
Castration-Resistant Prostate Cancer: Targeted Therapies and Individualized Treatment
Various molecular mechanisms have been implicated in the progression from hormone-sensitive to castration-resistant prostate cancer (CRPC). Novel targeted agents to treat CRPC have been developed that inhibit either androgen receptor (AR)-mediated signaling (AR antagonists and inhibitors of androgen...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AlphaMed Press
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3228103/ https://ncbi.nlm.nih.gov/pubmed/21339259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0216 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|